Boston Scientific, Medtronic, Abbott and J&J unveiled new data for their PFA devices in tandem with the Heart Rhythm ...

Inspectors found ICU Medical made multiple changes to infusion pumps without submitting premarket notifications.

McEvoy, the former leader of Johnson & Johnson’s medtech business, started immediately. Jim Hollingshead, who was CEO of ...

William Blair analyst Brandon Vazquez said 2025 could be the first year market leader Intuitive Surgical will face meaningful ...

While J&J, Abbott and Boston Scientific have all said the White House’s tariff policies will cost them hundreds of millions ...

An analysis of the timing of adverse event reports has convinced the company that raw material delivered by a vendor was the ...

Jon Monson, currently Boston Scientific's senior vice president for investor relations, will replace Brennan beginning June ...

Former Avanos Medical executive Michael Greiner has left the company. Greiner was CFO and chief transformation officer at the ...

Receiving FDA clearance would allow Medtronic to pair its pumps with a glucose monitor being developed for the company by ...

Trump administration policies have raised questions about how the FDA will regulate AI in medical devices. AdvaMed board members think the agency should keep its leading role.